论文部分内容阅读
既往曾报道,联用抗逆病毒药物治疗与心肌梗死(MI)风险增加有关。然而关于单用此类药物是否亦与MI风险增加皆有关目前尚未清楚。本义旨在就累积使用抗逆病毒类药物之一蛋白酶抑制剂或非核苷逆转录酶抑制剂与MI罹发风险间关系进行了分析。对象与方法受试对象为2005年前的22437例
It has been previously reported that combination antiretroviral therapy is associated with an increased risk of myocardial infarction (MI). However, it remains unclear whether such drugs alone are associated with an increased risk of MI. The original meaning of the cumulative use of anti-retroviral drugs, one of the protease inhibitors or non-nucleoside reverse transcriptase inhibitors and the risk of MI was analyzed. Subjects and methods subject to 22437 cases before 2005